About: Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.31 (-8.31%)
PBM NASDAQ Psyence Biomedical Ltd. Common Shares
Loading watchlist status…
Psyence Biomedical Ltd. Common Shares share price
PBM price activity
Last Price
$3.310
Change (24hr)
-0.30 USD (8.31%)
Volume
46.63K
Volume (4w avg)
-
Open
$3.51
Day Range
$3.28 - $3.64
Previous Close
$3.61
Last Trade
30 Oct, 8:23 pm GMT+0
Delayed
30 Oct, 8:23 pm GMT+0
PBM price performance
+9.97%
5D
-39.60%
1M
+339.34%
YTD
+4.75%
1Y
Delayed
30 Oct, 8:23 pm GMT+0
PBM Market Signals